Safety and efficacy of a new device for inducing ejaculation in men with spinal cord injuries.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 25082380.
- Also identified by DOI 10.1038/sc.2014.110.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Prospective case series. Male infertility is a common sequela of spinal cord injury (SCI). Fatherhood is a goal in this group of young patients; however, most are anejaculatory. Penile vibratory stimulation is recommended as the first line of treatment for this condition. Our study evaluated the safety and efficacy of a new device designed to induce ejaculation in these patients. The Miami Project to Cure Paralysis, Miami, FL, USA. The Viberect-X3 (Reflexonic, Frederick, MD, USA) was applied to 30 consecutive anejaculatory men with SCI whose level of injury was T10 and rostral. The ejaculatory success was 77% (23/30). No adverse events occurred, and there were no malfunctions of the device. In this first report on the efficacy of the Viberect-X3 for treatment of anejaculation in men with SCI, we conclude that the device is safe and effective for inducing ejaculation in men with SCI. Recommendation of the Viberect-X3 versus other devices intended for this purpose should not be made until randomized controlled trials are performed.
Medical subject headings
- Ejaculation
- Physical Stimulation
- Sexual Dysfunction, Physiological
- Spinal Cord Injuries
- Vibration